Co-Authors
This is a "connection" page, showing publications co-authored by JEFFREY J TARRAND and SAMUEL SHELBURNE.
Connection Strength
0.600
-
Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851.
Score: 0.139
-
Development and validation of a clinical model to predict the presence of ?-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients. Clin Infect Dis. 2014 Jul 15; 59(2):223-30.
Score: 0.125
-
Review of streptococcal bloodstream infections at a comprehensive cancer care center, 2000-2011. J Infect. 2013 Feb; 66(2):136-46.
Score: 0.113
-
Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-?-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy. Antimicrob Agents Chemother. 2019 02; 63(2).
Score: 0.044
-
Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia. Open Forum Infect Dis. 2018 Jul; 5(7):ofy167.
Score: 0.042
-
Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure. J Infect. 2017 03; 74(3):243-247.
Score: 0.037
-
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-?-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clin Infect Dis. 2016 10 01; 63(7):954-958.
Score: 0.036
-
GyrB polymorphisms accurately assign invasive viridans group streptococcal species. J Clin Microbiol. 2014 Aug; 52(8):2905-12.
Score: 0.032
-
Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients. Int J Antimicrob Agents. 2014 Jun; 43(6):558-62.
Score: 0.031